ArticleJournal of clinical medicine2023

Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data.

Tom Konikoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.